2256 — Abbisko Cayman Income Statement
0.000.00%
Last trade - 00:00
- HK$2.30bn
- HK$207.72m
- CNY19.06m
- 19
- 12
- 71
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 22.7 | 0 | 19.1 |
Cost of Revenue | |||||
Gross Profit | — | — | 22.7 | 0 | 19.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 133 | 706 | 1,832 | 493 | 448 |
Operating Profit | -133 | -706 | -1,809 | -493 | -429 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -134 | -707 | -1,810 | -496 | -432 |
Provision for Income Taxes | |||||
Net Income After Taxes | -134 | -707 | -1,810 | -496 | -432 |
Net Income Before Extraordinary Items | |||||
Net Income | -134 | -707 | -1,810 | -496 | -432 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -134 | -707 | -1,810 | -496 | -432 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.191 | -1.01 | -7.73 | -0.798 | -0.667 |